Hans Spiegel

4.5k total citations · 1 hit paper
71 papers, 3.0k citations indexed

About

Hans Spiegel is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Hans Spiegel has authored 71 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Infectious Diseases, 31 papers in Epidemiology and 24 papers in Virology. Recurrent topics in Hans Spiegel's work include HIV/AIDS Research and Interventions (35 papers), HIV Research and Treatment (24 papers) and Adolescent Sexual and Reproductive Health (15 papers). Hans Spiegel is often cited by papers focused on HIV/AIDS Research and Interventions (35 papers), HIV Research and Treatment (24 papers) and Adolescent Sexual and Reproductive Health (15 papers). Hans Spiegel collaborates with scholars based in United States, United Kingdom and South Africa. Hans Spiegel's co-authors include Douglas F. Nixon, Graham S. Ogg, Geraldine M. Gillespie, Andrew J. McMichael, Sean M. Donahoe, Sarah Rowland‐Jones, Abigail King, Celsa A. Spina, Philippa Easterbrook and Tao Dong and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Hans Spiegel

69 papers receiving 3.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function

2000 742 citations Victor Appay, Douglas F. Nixon et al. The Journal of Experimental Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hans Spiegel United States	27	1.3k	1.2k	1.2k	912	238	71	3.0k
Arye Rubinstein United States	34	1.5k 1.2×	1.1k 0.9×	1.3k 1.1×	1.4k 1.6×	154 0.6×	115	3.7k
Assan Jaye Gambia	33	1.3k 1.0×	1.0k 0.9×	1.2k 1.0×	891 1.0×	102 0.4×	81	2.8k
I. Celine Hanson United States	26	1.9k 1.4×	688 0.6×	801 0.7×	1.0k 1.1×	486 2.0×	64	2.9k
Jan C.C. Borleffs Netherlands	27	1.6k 1.2×	779 0.7×	1.4k 1.2×	1.0k 1.1×	256 1.1×	97	3.4k
Andrea Kovács United States	38	2.4k 1.9×	593 0.5×	1.7k 1.4×	1.8k 2.0×	306 1.3×	133	4.4k
Janine Jason United States	29	684 0.5×	727 0.6×	571 0.5×	651 0.7×	198 0.8×	89	3.0k
Alysse G. Wurcel United States	26	1.0k 0.8×	1.2k 1.0×	1.6k 1.4×	1.5k 1.6×	129 0.5×	101	3.5k
Richard M. Novak United States	29	1.6k 1.3×	391 0.3×	1.2k 1.1×	1.2k 1.3×	156 0.7×	76	3.3k
Lucy A. McNamara United States	23	1.1k 0.9×	550 0.5×	514 0.4×	1.2k 1.3×	99 0.4×	64	3.1k
Sergio Lo Caputo Italy	30	1.7k 1.3×	896 0.8×	1.7k 1.4×	860 0.9×	85 0.4×	147	3.2k

Countries citing papers authored by Hans Spiegel

Since Specialization

Citations

This map shows the geographic impact of Hans Spiegel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Spiegel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Spiegel more than expected).

Fields of papers citing papers by Hans Spiegel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Spiegel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Spiegel. The network helps show where Hans Spiegel may publish in the future.

Co-authorship network of co-authors of Hans Spiegel

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Spiegel. A scholar is included among the top collaborators of Hans Spiegel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Spiegel. Hans Spiegel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rutstein, Sarah E., Jane S. Chen, Yaw Agyei, et al.. (2025). Improving HIV Prevention Among Heterosexual Men Seeking Sexually Transmitted Infection Services in Malawi: Protocol for a Type I Effectiveness-Implementation Hybrid Randomized Controlled Trial of Systems Navigator–Delivered Integrated Prevention Package (HPTN 112-NJIRA Study). JMIR Research Protocols. 14. e72981–e72981.

Spiegel, Hans. (2025). Forum Junge Notfallmedizin anlässlich 40 Jahre BAND e. V. in Berlin. Notarzt. 41(1). 56–58.

Gill, Katherine, Melissa Wallace, Millicent Atujuna, et al.. (2023). “It’s already in your body and it’s preventing”: a qualitative study of African female adolescent’s acceptability and preferences for proxy HIV prevention methods in Cape Town, South Africa. BMC Public Health. 23(1). 2143–2143. 3 indexed citations

Politch, Joseph A., Susan Cu‐Uvin, Thomas R. Moench, et al.. (2021). Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial. PLoS Medicine. 18(2). e1003495–e1003495. 40 indexed citations

Agwu, Allison L., Meredith G. Warshaw, Elizabeth J. McFarland, et al.. (2017). Decline in CD4 T lymphocytes with monotherapy bridging strategy for non-adherent adolescents living with HIV infection: Results of the IMPAACT P1094 randomized trial. PLoS ONE. 12(6). e0178075–e0178075. 11 indexed citations

Robinson, Jennifer, Mark A. Marzinke, Rahul P. Bakshi, et al.. (2016). Comparison of Dapivirine Vaginal Gel and Film Formulation Pharmacokinetics and Pharmacodynamics (FAME 02B). AIDS Research and Human Retroviruses. 33(4). 339–346. 32 indexed citations

Guthrie, Kate M., Joseph L. Fava, Sara Vargas, et al.. (2016). A Comparative Pre-Phase I Study of the Impact of Gel Vehicle Volume on Distal Colon Distribution, User Experience, and Acceptability. AIDS Research and Human Retroviruses. 33(5). 440–447. 10 indexed citations

Nicol, Mark P., Devasena Gnanashanmugam, Renee Browning, et al.. (2015). A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric Tuberculosis: Table 1.. Clinical Infectious Diseases. 61(suppl 3). S164–S172. 22 indexed citations

Fuchs, Edward J., Mark A. Marzinke, Rahul P. Bakshi, et al.. (2015). A Phase 1 Randomized, Blinded Comparison of the Pharmacokinetics and Colonic Distribution of Three Candidate Rectal Microbicide Formulations of Tenofovir 1% Gel with Simulated Unprotected Sex (CHARM-02). AIDS Research and Human Retroviruses. 31(11). 1098–1108. 18 indexed citations

10.

McGowan, Ian, Ross Cranston, Cindy Jacobson, et al.. (2015). A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study). PLoS ONE. 10(5). e0125363–e0125363. 49 indexed citations

11.

Qian, Han‐Zhu, Douglas F. Milam, Hans Spiegel, et al.. (2014). Does Circumcision Offer Some Protection from HIV for Men who Have Sex with Men? A Cross-sectional Study in China. AIDS Research and Human Retroviruses. 30(S1). A197–A198. 1 indexed citations

12.

Mitchell, Charles D., Miriam C. Chernoff, George R. Seage, et al.. (2014). Predictors of resolution and persistence of renal laboratory abnormalities in pediatric HIV infection. Pediatric Nephrology. 30(1). 153–165. 4 indexed citations

13.

Jantausch, Barbara, et al.. (2009). HUMAN PARECHOVIRUS-3 INFECTION. The Pediatric Infectious Disease Journal. 28(6). 545–547. 53 indexed citations

14.

Rakhmanina, Natella, Edmund V. Capparelli, John N. van den Anker, et al.. (2007). Nevirapine Concentration in Nonstimulated Saliva: An Alternative to Plasma Sampling in Children with Human Immunodeficiency Virus Infection. Therapeutic Drug Monitoring. 29(1). 110–117. 17 indexed citations

15.

Sandberg, Johan K., Kimberly A. Jordan, Scott N. Furlan, et al.. (2003). HIV-Specific CD8+ T Cell Function in Children with Vertically Acquired HIV-1 Infection Is Critically Influenced by Age and the State of the CD4+ T Cell Compartment. The Journal of Immunology. 170(8). 4403–4410. 54 indexed citations

16.

Lechner, Franziska, John Sullivan, Hans Spiegel, et al.. (2000). Why do cytotoxic T lymphocytes fail to eliminate hepatitis C virus? Lessons from studies using major histocompatibility complex class I peptide tetramers. Philosophical Transactions of the Royal Society B Biological Sciences. 355(1400). 1085–1092. 24 indexed citations

17.

Appay, Victor, Douglas F. Nixon, Sean M. Donahoe, et al.. (2000). HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic Function. The Journal of Experimental Medicine. 192(1). 63–76. 742 indexed citations breakdown →

18.

Mulder, G.H., et al.. (1995). Epidemiology and Transmission. Gut. 37(Suppl 1). A68–A72. 1 indexed citations

19.

Spiegel, Hans, Hermann Herbst, Gerald Niedobitek, HD Foss, & H Stein. (1992). Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells.. PubMed Central. 140(1). 15–22. 191 indexed citations

20.

Spiegel, Hans, Stephen L. Leib, T Finn, et al.. (1992). Distribution of human immunodeficiency virus (HIV) in the CNS of children with severe HIV encephalomyelopathy. Acta Neuropathologica. 84(1). 24–31. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact